How Soon相关文献与解析，生知库 | 链接生命科学的每一步

Does dose reduction of afatinib affect treatment outcomes of patients with EGFR-mutant metastatic non-small cell lung cancer in real-world clinical practice?

在真实临床实践中，降低阿法替尼剂量是否会影响 EGFR 突变转移性非小细胞肺癌患者的治疗结果？

Poh, Mau Ern; Chai, Chee Shee; Liam, Chong Kin; Ho, Gwo Fuang; Pang, Yong Kek; Hasbullah, Harissa Husainy; Tho, Lye Mun; Muhamad Nor, Ibtisam; Ho, Kean Fatt; Thiagarajan, Muthukkumaran; Samsudin, Azlina; Omar, Azza; Ong, Choo Khoon; Soon, Sing Yang; Tan, Sin Nee; How, Soon Hin

肺癌

Real-world efficacy of low dose osimertinib as second-line treatment in patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer

低剂量奥希替尼作为二线治疗表皮生长因子受体突变晚期非小细胞肺癌患者的真实世界疗效

期刊:Translational Lung Cancer Research

影响因子:3.5

doi:10.21037/tlcr-24-243

Poh, Mau Ern; Balakrishnan, Sivasubramaniam; Tan, Sin Nee; Zainal Abidin, Muhammad Adil; Liam, Chong Kin; Tan, Jiunn Liang; Pang, Yong Kek; Alaga, Arvindran; Tho, Lye Mun; How, Soon Hin

Real-World Treatment and Outcomes of ALK-Positive Metastatic Non-Small Cell Lung Cancer in a Southeast Asian Country

东南亚某国ALK阳性转移性非小细胞肺癌的真实世界治疗及预后

期刊:Cancer Management and Research

影响因子:2.6

doi:10.2147/CMAR.S393729

Poh, Mau Ern; How, Soon Hin; Ho, Gwo Fuang; Pang, Yong Kek; Hasbullah, Harissa H; Tho, Lye Mun; Muhamad Nor, Ibtisam; Lim, Bee Chiu; Ho, Kean Fatt; Thiagarajan, Muthukkumaran; Samsudin, Azlina; Omar, Azza; Ong, Choo Khoon; Soon, Sing Yang; Tan, Justin Yu Kuan; Zainal Abidin, Muhammad Adil

Whole genome sequence analysis showing unique SARS-CoV-2 lineages of B.1.524 and AU.2 in Malaysia

全基因组序列分析显示马来西亚存在独特的 SARS-CoV-2 谱系 B.1.524 和 AU.2

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0263678

Ummu Afeera Zainulabid, Aini Syahida Mat Yassim, Mushtaq Hussain, Ayesha Aslam, Sharmeen Nellisa Soffian, Mohamad Shafiq Mohd Ibrahim, Norhidayah Kamarudin, Mohd Nazli Kamarulzaman, How Soon Hin, Hajar Fauzan Ahmad

Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia

东南亚发展中国家EGFR突变型晚期非小细胞肺癌患者的预后

期刊:Cancer Management and Research

影响因子:2.6

doi:10.2147/CMAR.S364713

How, Soon Hin; Liam, Chong Kin; Zainal Abidin, Muhammad Adil; Hasbullah, Harissa H; Tho, Lye Mun; Ho, Gwo Fuang; Muhamad Nor, Ibtisam; Pang, Yong Kek; Ho, Kean Fatt; Thiagarajan, Muthukkumaran; Ariffin, Roziana; Samsudin, Azlina; Omar, Azza; Tan, Sin Nee; Ong, Choo Khoon; Soon, Sing Yang; Poh, Mau Ern

Programmed death-ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non-small-cell lung cancer in a resource-limited country

资源匮乏国家晚期非小细胞肺癌患者程序性死亡配体1表达及免疫检查点抑制剂使用情况

期刊:Thoracic Cancer

影响因子:2.3

doi:10.1111/1759-7714.14442

How, Soon Hin; Tho, Lye Mun; Liam, Chong Kin; Hasbullah, Harissa H; Ho, Gwo Fuang; Muhammad Nor, Ibtisam; Poh, Mau Ern; Ho, Kean Fatt; Thiagarajan, Muthukkumaran; Samsudin, Azlina; Omar, Azza; Ong, Choo Khoon; Pang, Yong Kek; Soon, Sing Yang

Limited doses of immunotherapy use in advanced non-small cell lung cancer elderly patients with ECOG of 2 and high PDL-1 expression

对于ECOG评分2分且PD-L1表达高的晚期非小细胞肺癌老年患者，可采用有限剂量的免疫疗法。

期刊:Aging Medicine

影响因子:2.5

doi:10.1002/agm2.12179

Wong, Pui Yee; How, Soon Hin; Hassan, Radhiana; Abdul Azih, Muhammad Naimmuddin

Cancer-Associated Thrombosis: A Clinical Scoping Review of the Risk Assessment Models Across Solid Tumours and Haematological Malignancies

癌症相关血栓形成：实体瘤和血液系统恶性肿瘤风险评估模型的临床范围综述

期刊:International Journal of General Medicine

影响因子:2

doi:10.2147/IJGM.S320492

Mosaad, Manar; Elnaem, Mohamed Hassan; Cheema, Ejaz; Ibrahim, Ismail; Ab Rahman, Jamalludin; Kori, Ahlam Naila; Hin, How Soon

Emerging respiratory infections threatening public health in the Asia-Pacific region: A position paper of the Asian Pacific Society of Respirology

亚太地区新发呼吸道感染威胁公众健康：亚太呼吸学会立场文件

期刊:Respirology

影响因子:6.3

doi:10.1111/resp.13558

Park, Sunghoon; Park, Ji Young; Song, Yuanlin; How, Soon Hin; Jung, Ki-Suck

炎症/感染

发表日期：2019

文献求助收藏

Advancing Precision Medicine in Non-Small Cell Lung Cancer Diagnostics in a Southeast Asian Country

在东南亚某国推进非小细胞肺癌诊断的精准医疗

Does dose reduction of afatinib affect treatment outcomes of patients with EGFR-mutant metastatic non-small cell lung cancer in real-world clinical practice?

在真实临床实践中，降低阿法替尼剂量是否会影响 EGFR 突变转移性非小细胞肺癌患者的治疗结果？

Real-world efficacy of low dose osimertinib as second-line treatment in patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer

低剂量奥希替尼作为二线治疗表皮生长因子受体突变晚期非小细胞肺癌患者的真实世界疗效

Real-World Treatment and Outcomes of ALK-Positive Metastatic Non-Small Cell Lung Cancer in a Southeast Asian Country

东南亚某国ALK阳性转移性非小细胞肺癌的真实世界治疗及预后

Whole genome sequence analysis showing unique SARS-CoV-2 lineages of B.1.524 and AU.2 in Malaysia

全基因组序列分析显示马来西亚存在独特的 SARS-CoV-2 谱系 B.1.524 和 AU.2

Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia

东南亚发展中国家EGFR突变型晚期非小细胞肺癌患者的预后

Programmed death-ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non-small-cell lung cancer in a resource-limited country

资源匮乏国家晚期非小细胞肺癌患者程序性死亡配体1表达及免疫检查点抑制剂使用情况

Limited doses of immunotherapy use in advanced non-small cell lung cancer elderly patients with ECOG of 2 and high PDL-1 expression

对于ECOG评分2分且PD-L1表达高的晚期非小细胞肺癌老年患者，可采用有限剂量的免疫疗法。

Cancer-Associated Thrombosis: A Clinical Scoping Review of the Risk Assessment Models Across Solid Tumours and Haematological Malignancies

癌症相关血栓形成：实体瘤和血液系统恶性肿瘤风险评估模型的临床范围综述

Emerging respiratory infections threatening public health in the Asia-Pacific region: A position paper of the Asian Pacific Society of Respirology

亚太地区新发呼吸道感染威胁公众健康：亚太呼吸学会立场文件